Globeflex Capital’s Enzo Biochem ENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding ENZ
Globeflex Capital's ENZ Position: Q2 2018 in Review
Globeflex Capital sold out of Enzo Biochem (ENZ) in Q2 2018, closing a stake of 7,880 shares — an estimated $43K sold.
Globeflex Capital first reported a position in ENZ in Q1 2015 and held it in 8 quarters. The position peaked at $1.55M in Q4 2016. 97 funds tracked by Wall St. Rank hold ENZ as of Q2 2018.
- Globeflex Capital reported no remaining Enzo Biochem position as of Q2 2018 after selling out during the quarter.
- Globeflex Capital sold 7,880 Enzo Biochem shares in Q2 2018, an estimated $43K.
- Globeflex Capital first reported a position in Enzo Biochem in Q1 2015 and held it in 8 quarters.
- Globeflex Capital's Enzo Biochem position peaked at $1.55M in Q4 2016.
- 97 funds tracked by Wall St. Rank held Enzo Biochem as of Q2 2018.
Based on Globeflex Capital's 13F filing for Q2 2018, filed 10 Aug 2018.